ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.59
1.05%
US Tech 100
20,333.60
1.61%
S&P 500
5,954.50
1.59%
US Dollar vs CAD
1.44675
0.00%
Bitcoin
83,861.54
-0.61%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Alto Neuroscience Inc (ANRO) Share Price

Alto Neuroscience Inc

Alto Neuroscience Inc (ANRO)

NYSE
2.80
0.02
(0.72%)
Closed February 28 3:00PM
Delayed by 15 minutes
2.80
0.00
(0.00%)
After Hours: 6:05PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
2.80
Bid
-
Ask
-
Volume
286,068
2.67 Day's Range 2.82
2.75 52 Week Range 18.3499
Market Cap
75.516M
Previous Close
2.78
Open
2.76
Last Trade
25527
@
2.8
Last Trade Time
Financial Volume
US$ 784,224
VWAP
2.7414
Average Volume (3m)
259,953
Shares Outstanding
26,970,168
Dividend Yield
-
PE Ratio
-2.08
Earnings Per Share (EPS)
-1.35
Revenue
-
Net Profit
-36.31M

About Alto Neuroscience Inc

Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine neuropsychiatric care by leveraging neurobiology to develop personalized and highly effective treatment options. Through our AI-enabled biomarker platform, we combine rich sources of information on patients' b... Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine neuropsychiatric care by leveraging neurobiology to develop personalized and highly effective treatment options. Through our AI-enabled biomarker platform, we combine rich sources of information on patients' brain activity and behavior to better identify which patients are more likely to respond to our novel product candidates. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.altoneuroscience.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Alto Neuroscience Inc is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker ANRO. The last closing price for Alto Neuroscience was US$2.78. Over the last year, Alto Neuroscience shares have traded in a share price range of US$ 2.75 to US$ 18.3499.

Alto Neuroscience currently has 26,970,168 shares outstanding. The market capitalization of Alto Neuroscience is US$74.98 million. Alto Neuroscience has a price to earnings ratio (PE ratio) of -2.08.

Ask ADVFN Intelligence (AI)

ANRO Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
February 12 2025
ANRO (0.72%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
February 11 2025
ANRO (0.72%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 07 2025
ANRO (0.72%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 07 2025
ANRO (0.72%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 07 2025
ANRO (0.72%)

Form 8-K - Current report
Edgar (US Regulatory)
February 03 2025
ANRO (0.72%)

Form S-3 - Registration statement under Securities Act of 1933
Edgar (US Regulatory)
February 03 2025
ANRO (0.72%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.38-11.94968553463.183.2422.752119112.95659583CS
4-1.66-37.21973094174.464.692.752551763.42990358CS
12-1.182-29.68357609243.9824.882.752599533.88895919CS
26-9.04-76.351351351411.8415.042.755200646.58171042CS
52-12.13-81.245813797714.9318.34992.753456678.15890603CS
156-19.2-87.272727272722242.753467078.77323175CS
260-19.2-87.272727272722242.753467078.77323175CS

ANRO - Frequently Asked Questions (FAQ)

What is the current Alto Neuroscience share price?
The current share price of Alto Neuroscience is US$ 2.80
How many Alto Neuroscience shares are in issue?
Alto Neuroscience has 26,970,168 shares in issue
What is the market cap of Alto Neuroscience?
The market capitalisation of Alto Neuroscience is USD 74.98M
What is the 1 year trading range for Alto Neuroscience share price?
Alto Neuroscience has traded in the range of US$ 2.75 to US$ 18.3499 during the past year
What is the PE ratio of Alto Neuroscience?
The price to earnings ratio of Alto Neuroscience is -2.08
What is the reporting currency for Alto Neuroscience?
Alto Neuroscience reports financial results in USD
What is the latest annual profit for Alto Neuroscience?
The latest annual profit of Alto Neuroscience is USD -36.31M
What is the registered address of Alto Neuroscience?
The registered address for Alto Neuroscience is CORPORATION TRUST CENTER, 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Alto Neuroscience website address?
The website address for Alto Neuroscience is www.altoneuroscience.com
Which industry sector does Alto Neuroscience operate in?
Alto Neuroscience operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
OMIOwens and Minor Inc
US$ 9.60
(39.33%)
12.11M
TPCTutor Perini Corporation
US$ 29.44
(34.61%)
1.87M
OCFTOneConnect Financial Technology Co Ltd
US$ 5.32
(22.34%)
1.41M
ARLOArlo Technologies Inc
US$ 14.38
(20.64%)
3M
PRGOPerrigo Company Plc Ireland
US$ 29.01
(20.22%)
7.58M
DVDoubleVerify Holdings Inc
US$ 13.895
(-36.06%)
14.92M
AMRCAmeresco Inc
US$ 11.80
(-35.62%)
3.51M
KINDNextdoor Holdings Inc
US$ 1.765
(-29.12%)
15.96M
EBEventbrite Inc
US$ 2.42
(-21.94%)
5.66M
FEDUFour Seasons Education Cayman Inc
US$ 8.26
(-21.71%)
5.21k
LYGLloyds Banking Group Plc
US$ 3.74
(1.36%)
243.89M
NUNu Holdings Ltd
US$ 10.75
(-4.44%)
139.76M
FFord Motor Company
US$ 9.54
(2.69%)
137.99M
BCSBarclays PLC
US$ 15.87
(1.15%)
100.07M
AESAES Corp
US$ 11.59
(11.66%)
71.51M

Discussion

View Full Feed
Perk_Idaho Perk_Idaho 3 minutes ago
Weird that any investor would have negative things to say today......
NWBO
JP313 JP313 3 minutes ago
Can you shoot a few safe tickers to do some dd on & possibly invest?
CRSM
falconer66a falconer66a 3 minutes ago
Online Blarcamesine Sales
Do you think the smaller market size will allow Anavex to effectively market 2-73 on a direct basis without the need for a partner?
Blarcamesine is a small molecule, for which Anavex has patent-protected methods for its synthesis. Simply, Anavex can contract
AVXL
rocketeer357 rocketeer357 4 minutes ago
Time for Cashbag to start saying nice things about Stroman: https://www.mlb.com/news/luis-gil-shoulder-injury
Hopefully it's too late and the Yanks have put Stroman offside with all of the trade and bulllpen talk. I'd love to see him hit 141 innings this season.
kid70 kid70 4 minutes ago
I don't think RS will happen
UBQU
Mrhumble59 Mrhumble59 5 minutes ago
Surprise, surprise another gray matter challenged person throwing the SCAM word around. Again, send me 5 bullet points outlining what a scam company is comprised of. None of you bashers have met the challenge as of yet. So Stifle Edith unless you can do so.
HMBL
badog badog 7 minutes ago
I would have to think that he is coming to the realization that there are no shorts. And because of that his short squeeze scenario is not working. I think you are correct that he doesn't want PN to address shareholders. Huge risk of exposing what could be the final nail in this coffin. The
ERHE
WhenMoon WhenMoon 7 minutes ago
Well the quote from Mr. Hakim is only 8 months old so who knows, maybe it could be the cherry on top if it did unluck some extra value but its not critical.
My understanding of the $2.10 outside valuation from 2014 was based on roughly 500 million shares at the time and compromised primaril
ELTP
STL Stock STL Stock 7 minutes ago
Many can profit off the greater fool theory regarding investing/trading.
HMBL
Triple nickle Triple nickle 7 minutes ago
Population goes up so does the market I remember being on stockhideout in 2010/11 that the Dow is headed to 25000 and got laughed at. 
JoeForkeyBolo JoeForkeyBolo 8 minutes ago
Will, after putting together 10-year historical data on BTC price, it seems pointless to run a comparison to buy-and-hold for this. There's no way AIM will even be remotely close given the price trajectory from $275 on Day 1 of the 10-year period to approximately $80,500 at the current level.
BITX
arizona1 arizona1 8 minutes ago
Did Russia invade Ukraine.....yes or no?
MRJ25 MRJ25 9 minutes ago
Very positive. Pulte, Bessent et al have said that CON-ship exit depends on interest rate.
FNMA
rooster rooster 10 minutes ago
What about Russia invading Ukraine
JPetroInc JPetroInc 11 minutes ago
right you are sir...!

imagizer.imageshack.com/v2/1600x1200q70/924/SnD7tb.jpg

way too many free cheap dirty shares issued to crony's

sad $MONI...!

AJMHO
MONI
Uncle Monkey Uncle Monkey 11 minutes ago
just more fake news from fake news mod...

pathetic
CBRF
arizona1 arizona1 12 minutes ago
What about that

Translate that into English please or at least rephrase it so we understand what you're talking about.
vinmantoo vinmantoo 13 minutes ago
They'll be fine. Just need to partner up

That would make me and my bank account very happy.
ENTA
arizona1 arizona1 13 minutes ago
Your Medicaid no longer covers eye rolls.
janice shell janice shell 13 minutes ago
Now this is interesting. Did Bezos give his editorial board the green light to run this, or did they defy him?

In acrimonious meeting, Trump berates Zelensky
The president should try being as kind to America’s friend as he is to Putin.

Today at 6;56 p.m. EST
janice shell janice shell 14 minutes ago
Now this is interesting. Did Bezos give his editorial board the green light to run this, or did they defy him?

In acrimonious meeting, Trump berates Zelensky
The president should try being as kind to America’s friend as he is to Putin.

Today at 6;56 p.m. EST
rooster rooster 14 minutes ago
What about that
Slojab Slojab 14 minutes ago
EU foreign policy chief Kaja Kallas said that "Today, it became clear that the free world needs a new leader,"
janice shell janice shell 15 minutes ago
Now this is interesting. Did Bezos give his editorial board the green light to run this, or did they defy him?

In acrimonious meeting, Trump berates Zelensky
The president should try being as kind to America’s friend as he is to Putin.

Today at 6;56 p.m. EST

Your Recent History

NYSE
ANRO
Alto Neuroscience
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads